Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03429101
Title A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Pacific Cancer Medical Center, Inc. Anaheim California 92801 United States Details
Los Angeles Hematology Oncology Medical Group Glendale California 91204 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field